- Home
- FSEA vs SER Comparison
FSEA vs SER Comparison
Compare FSEA & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- SER
- Stock Information
- Founded
- FSEA 1890
- SER 2017
- Country
- FSEA United States
- SER United States
- Employees
- FSEA N/A
- SER N/A
- Industry
- FSEA Savings Institutions
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- FSEA Finance
- SER Health Care
- Exchange
- FSEA Nasdaq
- SER Nasdaq
- Market Cap
- FSEA 51.2M
- SER 47.5M
- IPO Year
- FSEA N/A
- SER 2018
- Fundamental
- Price
- FSEA $11.65
- SER $5.82
- Analyst Decision
- FSEA
- SER Strong Buy
- Analyst Count
- FSEA 0
- SER 1
- Target Price
- FSEA N/A
- SER $11.00
- AVG Volume (30 Days)
- FSEA 7.6K
- SER 9.7K
- Earning Date
- FSEA 03-21-2025
- SER 03-24-2025
- Dividend Yield
- FSEA N/A
- SER N/A
- EPS Growth
- FSEA N/A
- SER N/A
- EPS
- FSEA N/A
- SER N/A
- Revenue
- FSEA $15,874,000.00
- SER $56,000.00
- Revenue This Year
- FSEA N/A
- SER N/A
- Revenue Next Year
- FSEA N/A
- SER N/A
- P/E Ratio
- FSEA N/A
- SER N/A
- Revenue Growth
- FSEA 70.41
- SER N/A
- 52 Week Low
- FSEA $8.25
- SER $3.81
- 52 Week High
- FSEA $11.65
- SER $14.57
- Technical
- Relative Strength Index (RSI)
- FSEA 74.99
- SER 71.28
- Support Level
- FSEA $11.32
- SER $4.60
- Resistance Level
- FSEA $11.45
- SER $4.85
- Average True Range (ATR)
- FSEA 0.14
- SER 0.39
- MACD
- FSEA 0.02
- SER 0.13
- Stochastic Oscillator
- FSEA 100.00
- SER 100.00
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.